MKI67 and breast carcinoma: We collated four consecutive years of breast cancer data from our institution, and herein, we scrutinise the performance of Ki67 in surrogate molecular subtyping and explore the impact of artificial intelligence (AI) on delineating luminal tumours, as compared against gene expression test results.